Cargando…
The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•
Autores principales: | Ritchie, Rebecca, Irvine, Jennifer, Cao, Nga, Gossain, Swati, Alexander, Amy, Love, Jane, Qin, Chengxue, Horowitz, John D, Kemp-Harper, Barbara K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765528/ http://dx.doi.org/10.1186/2050-6511-14-S1-P56 |
Ejemplares similares
-
Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
por: Lin, Eliane Q., et al.
Publicado: (2012) -
The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP
por: Ritchie, Rebecca, et al.
Publicado: (2009) -
Dual Mechanisms of HNO Generation by a Nitroxyl Prodrug of the Diazeniumdiolate (NONOate) Class
por: Andrei, Daniela, et al.
Publicado: (2010) -
Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro
por: Ritchie, Rebecca, et al.
Publicado: (2009) -
Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
por: Ritchie, Rebecca, et al.
Publicado: (2013)